The Effect of Respiratory Challenge on the BOLD Signal
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Feb 3, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Healthy adult subjects (\>18 years old) OR adult patients (\>18 years old) diagnosed with vascular pathology of the brain willing to participate and sign a consent form.
- • 2. Able to participate in MRI scan without sedation
- • 3. Not on stimulant medications
- • 4. No psychiatric history, as defined by seeing a psychiatrist for medical evaluation and treatment, or taking anti-depressant medications
- • 5. No seizure history
- • 6. May have occasional headaches if not taking a daily preventative medication for headaches
- • 7. Not on vasodilatory medication, such as sildenafil or verapamil
- Exclusion Criteria:
- • 1. Subjects refusing to undergo testing
- • 2. Subjects with obstructive or resistive lung disease whose PaCO2 at rest is greater than 50mmHg or whose venous serum bicarbonate is greater than 26 mEq/L
- • 3. Subjects with pre-existing respiratory or metabolic acidosis
- • 4. Subjects who require portable oxygen at rest or with exercise
- • 5. Subjects with chronic heart failure or severe pulmonary disease who are unable to climb one flight of stairs due to shortness of breath
- • 6. Subjects with severe heart failure or restrictive lung disease with resting respiratory rate over 15 breaths/min 2. Patients that cannot participate in a course of rehabilitation therapy.
- 7. Subjects that cannot undergo an MRI scan due to one of the following indications:
- • Pregnancy
- • Obtundation, or Coma
- • Confusion, Delirium, or Dementia
- • Unable to understand or carry out commands regarding keeping still and breathing pattern
- • Increased intracranial pressure due to space occupying lesion or obstruction of outflow of CSF
- • Claustrophobia
- • History of kidney problems
- • Pace makers
- • Skin tattoos
- • Neurostimulators (TENS-unit)
- • Implanted drug infusion device (i.e., insulin pump)
- • Exposure of metal fragments to your eye
- • Artificial heart valves
- • Aneurysm clips
- • Cochlear implants
- • Metallic implants and prosthesis
- • Vascular stent or stent graft
- • History as a metal worker
- • Shrapnel or bullet wounds
- • Dorsal column stimulators
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials